Metabolomics is employed in cancer research to identify biomarkers for early detection, understand tumor metabolism, and develop personalized treatment strategies. By comparing the metabolic profiles of cancerous and normal tissues, researchers can pinpoint specific metabolic pathways that are altered in cancer. This can lead to the discovery of novel therapeutic targets.
